The short answer
Coffee naturally contains acrylamide, a listed chemical, which led to litigation demanding cancer warnings. But after reviewing the evidence, California adopted a rule in 2019 stating that coffee does not require a Prop 65 cancer warning — a rare, evidence-based course correction.
Acrylamide forms naturally when coffee beans are roasted.
Acrylamide is a listed Prop 65 chemical, prompting lawsuits over coffee warnings.
In 2019, OEHHA adopted a rule that coffee does not require a cancer warning.
The decision drew on IARC's finding that coffee is not classifiable as a carcinogen.
Choose how you want to understand this
The full explanation.
When a warning almost landed on your morning coffee
Few Prop 65 episodes illustrate hazard versus risk better than the fight over coffee.
Here's the setup. When coffee beans are roasted, a chemical called acrylamide forms naturally. Acrylamide is on the Proposition 65 list. Under a strict, hazard-based reading of the law, that meant coffee sellers might be required to warn customers that coffee exposes them to a listed chemical.
The lawsuit
A group brought litigation (widely known through the case against major coffee sellers, including Starbucks) arguing exactly that: because coffee contains listed acrylamide, sellers had to post cancer warnings. Early rulings went against the coffee industry, and for a time it looked like California cafes might have to warn that coffee causes cancer.
To many people, that felt absurd — and the science suggested it was.
The evidence pushed back
By this point, the International Agency for Research on Cancer had completed its major 2016 review of coffee. Its conclusion: coffee is "not classifiable" (Group 3), the earlier concern was not supported, and coffee may even be associated with lower risk of some cancers, such as liver and endometrial cancer. (See our page on coffee and cancer risk.)
In short, the best available evidence said coffee — despite containing a listed chemical — does not pose a significant cancer risk.
California's course correction
Faced with this, OEHHA took an unusual step. Rather than let the hazard-based trigger force warnings the science didn't support, it adopted a specific regulation, effective in 2019, stating that exposures to chemicals in coffee created by roasting and brewing do not require a Prop 65 cancer warning.
In effect, California carved out coffee, letting the weight of the evidence override the automatic hazard trigger.
Why this story matters
The coffee saga is a compact lesson in everything this section teaches:
- Hazard is not risk. Acrylamide is a genuine hazard, but its presence in coffee — alongside coffee's overall evidence — does not add up to significant risk.
- The system can self-correct. When a purely hazard-based rule threatened to produce a misleading warning, regulators used the evidence to fix it.
- Warnings are only as useful as their accuracy. A coffee cancer warning would have added noise, not information — the very over-warning problem critics point to.
The bottom line
Coffee was nearly saddled with a cancer warning because it naturally contains a listed chemical. California ultimately decided it does not require one, guided by the scientific evidence. It's one of the clearest real-world examples of choosing risk over raw hazard — and a reassuring one for coffee drinkers.
Words to know
Tap any term to see what it means.
Common questions
▸Why was coffee nearly required to carry a cancer warning?
Roasting coffee produces acrylamide, a chemical on the Prop 65 list. A lawsuit argued that coffee sellers therefore had to warn customers about acrylamide's cancer listing.
▸What did California decide?
After reviewing the science, OEHHA adopted a regulation, effective in 2019, stating that exposure to chemicals in coffee from roasting and brewing does not pose a significant cancer risk — so coffee does not require a Prop 65 cancer warning.
▸What evidence supported that decision?
IARC's 2016 review classified coffee as 'not classifiable' (Group 3) and noted evidence that coffee may even be associated with lower risk of some cancers. This weighed against requiring a warning.
▸What's the lesson?
It shows how a purely hazard-based trigger (acrylamide is listed) can be overridden when the overall evidence shows the real-world risk is not significant — a win for risk-based thinking.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.